深圳市海王生物工程股份有限公司2026年第一次临时股东会决议公告

Core Viewpoint - The announcement details the resolutions passed during the first extraordinary general meeting of shareholders for Shenzhen Haiwang Biological Engineering Co., Ltd. in 2026, confirming the legality and validity of the meeting and its decisions [1][5][13]. Meeting Details - The meeting was held on January 16, 2026, at 14:50, with both on-site and online voting options available [3][4]. - The location of the meeting was at the 24th floor of Haiwang Galaxy Technology Building, Nanshan District, Shenzhen [4]. - The meeting was chaired by Mr. Zhang Feng, the chairman and president of the board [5]. Attendance - A total of 1,404 shareholders attended the meeting, representing 1,242,292,136 shares, which is 47.2153% of the total voting shares [6]. - Among these, 4 shareholders attended in person, representing 1,219,283,921 shares (46.3408%), while 1,400 shareholders participated via online voting, representing 23,008,215 shares (0.8745%) [6][7]. - A total of 1,402 minority shareholders participated, representing 24,515,915 shares (0.9318%) [8]. Resolutions Passed - The first resolution regarding the transfer of equity in a controlling subsidiary, which resulted in external financial assistance, was approved with 99.4052% of the votes in favor [10]. - The second resolution concerning the continuation of guarantees constituting external guarantees was also approved, with 99.3765% of the votes in favor [11]. Legal Verification - The meeting was witnessed by lawyers from Beijing Deheng (Shenzhen) Law Firm, who confirmed that the meeting's procedures and resolutions complied with relevant laws and regulations [12][13].